Lv61
2840 积分 2022-08-19 加入
MDS-1497: Primary Analysis of the Randomized, Phase 3 VERONA Study of Venetoclax With Azacitidine Versus Placebo With Azacitidine in Patients With Treatment-Naïve, Intermediate and Higher-Risk Myelodysplastic Syndromes
18天前
已完结
Designing Robust Monoclonal Antibody Drug Products: Pitfalls of Simplistic Approaches for Stability Prediction
1个月前
已完结
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics
1个月前
已完结
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study
1个月前
已完结
In-depth Characterization of Photo-Stressed Antibody–Drug Conjugates by Mass Spectrometry
2个月前
已完结
Formulation of Monoclonal Antibody Therapies
3个月前
已完结
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery
3个月前
已完结
An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug Products
6个月前
已完结
Current Industry Best Practice on in-use Stability and Compatibility Studies for Biological Products
6个月前
已完结
Colloidal Stability Assessment of a Model Antibody Oligonucleotide Conjugate
6个月前
已完结